Valeria Pontelli

Valeria Pontelli

Auto-generated profile, based on publicly available information

Valeria Pontelli

Department of Neurological and Movement Sciences, Section of Physiology, University of Verona, Strada le Grazie 8, 37134 Verona, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Developmental Cell
Verified
Journal Article
Closed access
RFRafael Dominik Fritz
Rafael Dominik Fritz
DMDenis Menshykau
Denis Menshykau
KMKatrin Martin
Katrin Martin
ARAndreas Reimann
Andreas Reimann
VPValeria Pontelli
Valeria Pontelli
OPOlivier Pertz
Olivier Pertz

29 May 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ELErika Lorenzetto
Erika Lorenzetto
MEMichele Ettorre
Michele Ettorre
VPValeria Pontelli
Valeria Pontelli
MBMatteo Bolomini-Vittori
Matteo Bolomini-Vittori
SBSilvia Bolognin
Silvia Bolognin
MBMario Buffelli
Mario Buffelli
In adult mammals, after optic nerve injury, retinal ganglion cells (RGCs) do not regenerate their axons and most of them die by apoptosis within a few days. Recently, several strategies that activate neuronal intracellular pathways were proposed to prevent such degenerative processes. The rho-related small GTPase Rac1 is part of a complex, still not fully understood, intracellular signaling network, mediating in neurons many effects, including axon growth and cell survival. However, its role in neuronal survival and regeneration in vivo has not yet been properly investigated. To address this point we intravitreally injected selective cell-penetrating Rac1 mutants after optic nerve crush and studied the effect on RGC survival and axonal regeneration. We injected two well-characterized L61 constitutively active Tat-Rac1 fusion protein mutants, in which a second F37A or Y40C mutation confers selectivity in downstream signaling pathways. Results showed that, 15 days after crush, both mutants were able to improve survival and to prevent dendrite degeneration, while the one harboring the F37A mutation also improved axonal regeneration. The treatment with F37A mutant for one month did not improve the axonal elongation respect to 15 days. Furthermore, we found an increase of Pak1 T212 phosphorylation and ERK1/2 expression in RGCs after F37A treatment, whereas ERK1/2 was more activated in glial cells after Y40C administration. Our data suggest that the selective activation of distinct Rac1-dependent pathways could represent a therapeutic strategy to counteract neuronal degenerative processes in the retina.

1 June 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SASabrina Asteriti
Sabrina Asteriti
GCGiuditta Dal Cortivo
Giuditta Dal Cortivo
VPValeria Pontelli
Valeria Pontelli
Lorenzo CangianoLorenzo Cangiano
Lorenzo Cangiano
MBMario Buffelli
Mario Buffelli
DDDaniele Dell'Orco
Daniele Dell'Orco

24 April 2013 in Bioinformatics
Verified
Journal Article
Open access
PDF file
SZSimone Zorzan
Simone Zorzan
ELErika Lorenzetto
Erika Lorenzetto
MEMichele Ettorre
Michele Ettorre
VPValeria Pontelli
Valeria Pontelli
CLCarlo Laudanna
Carlo Laudanna
MBMario Buffelli
Mario Buffelli
Motivation: Comparative studies are encouraged by the fast increase of data availability from the latest high-throughput techniques, in particular from functional genomic studies. Yet, the size of datasets, the challenge of complete orthologs findings and not last, the variety of identification formats, make information integration challenging. With HOMECAT, we aim to facilitate cross-species relationship identification and data mapping, by combining orthology predictions from several publicly available sources, a convenient interface for high-throughput data download and automatic identifier conversion into a Cytoscape plug-in, that provides both an integration with a large set of bioinformatics tools, as well as a user-friendly interface.